| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Bladder Cancer | |||||
| Breast Cancer | |||||
| Head and Neck Cancer | |||||
| Lung Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Breast Neoplasms | |||||
| Head and Neck Neoplasms | |||||
| Lung Neoplasms | |||||
| Urinary Bladder Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Breast Diseases | |||||
| Lung Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Site | |||||
| Respiratory Tract Diseases | |||||
| Respiratory Tract Neoplasms | |||||
| Skin Diseases | |||||
| Thoracic Neoplasms | |||||
| Urinary Bladder Diseases | |||||
| Urogenital Neoplasms | |||||
| Urologic Diseases | |||||
| Urologic Neoplasms | |||||
| 4 | Interventions listed in this trial | ||||
| docetaxel | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antineoplastic Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Cancer and Leukemia Group B | |||||
| National Cancer Institute (NCI) | |||||
|
